Avycaz (ceftazidime and avibactam)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
June 2016
ADVERSE REACTIONS
Clinical Trial Experience
(addition of new paragraph) AVYCAZ was evaluated in four active-controlled...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts
More News: Clinical Trials | Drugs & Pharmacology